[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Midwestern University\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":118},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,41,64,92],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100608584","testing-educational-modalities-for-temporomandibular-disorders-curriculum-100608584",false,"NCT07203456","Testing Educational Modalities for Temporomandibular Disorders Curriculum","Inclusion Criteria:\n\n* Third or Fourth year dental students at the College of Dental Medicine at Midwestern University (Illinois)\n\nExclusion Criteria:\n\n* Dental students not enrolled at the third and\u002For fourth year of the College of Dental Medicine at Midwestern University (Illinois)",true,"ALL","18 Years",{"count":19,"type":20},90,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study is done to assess the change in confidence level, knowledge, and diagnostic ability in TMD-related aspects through the exposure to a Virtual Patient-Based Learning (VPBL) platform featuring temporomandibular disorder (TMD) cases among 3rd and 4th year predoctoral dental students at a larger predoctoral school.",[26,27],"Confidence","Diagnostic Ability","RECRUITING","2025-09-24",{"date":31,"type":32},"2025-10-02","ACTUAL",{"date":34,"type":32},"2025-06-13",{"date":36,"type":20},"2026-10-01",{"name":38,"class":39},"Midwestern University","OTHER",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":15,"sex":16,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":4,"studyType":21,"phases":52,"briefSummary":53,"conditions":54,"keywords":4,"overallStatus":56,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":4},"100574363","exercise-effects-in-native-american-adolscents-100574363","NCT06758310","Exercise Effects in Native American Adolscents","Effects of an Individualized Exercise Program on Physical Performance Measures in Southwest Native American Adolescents","Inclusion Criteria:\n\n* Active members of the Gila River Indian Community (GRIC) with Native American ancestry\n* Ages 11-17\n\nExclusion Criteria:\n\n* Not active members of the GRIC or no Native American ancestry\n* Age \\\u003C11 or \\>17","11 Years","17 Years",{"count":51,"type":20},10,[23],"This longitudinal study will investigate effects of exercise participation in Southwest Native American adolescents, ages 11-17, from the Gila River Indian Community. Vital signs, physical activity participation adherence, physical performance measures, and psychological\u002Fsocial measures will be assessed. Participants will attend one educational presentation for the initial session, explaining the benefits of physical exercise and expectations throughout the program. Baseline measurements for strength, flexibility, and cardiovascular fitness will be taken as well as height, weight and blood pressure. Based on individual performance measures, each participant will be provided a personalized exercise program to complete 3-4 times\u002Fweek for the duration for the duration of the study. Participants will also be provided an exercise journal to track their adherence to their exercise program each week. At the end of the session parents and adolescents separately will be asked to complete a written survey assessing physical, emotional, social, and school function. Physical performance measures will be taken every other week from the initial education and data collection session through 6 weeks.",[55],"Fitness Testing","NOT_YET_RECRUITING",{"date":58,"type":32},"2025-09-25",{"date":60,"type":20},"2025-11-16",{"date":62,"type":20},"2025-12-20",{"name":38,"class":39},{"id":65,"slug":66,"hasResults":11,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":72,"enrollmentInfo":73,"targetDuration":4,"studyType":21,"phases":75,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":40},"100570869","noninvasive-brain-stimulation-in-adult-amblyopia-100570869","NCT06712849","Noninvasive Brain Stimulation in Adult Amblyopia","Multi-day Effect of Noninvasive Brain Stimulation in Adults With Amblyopia","NIBSAAM","Inclusion Criteria:\n\n* Adults between 18 and 55 years of age\n* Formal diagnosis of amblyopia in one or both eyes of any etiology\n\nExclusion Criteria:\n\n* History of optic nerve disease, including glaucoma and optic neuritis\n* History of neurological conditions, including demyelinating disease or stroke\n* Presence of metal or electronic implants in or on the body, including pacemakers\n* Taking medications that can affect normal neurological function, including antipsychotics, antiepileptics, and opioids","55 Years",{"count":74,"type":20},60,[23],"The goal of this randomized controlled trial is to investigate the effectiveness of non-invasive brain stimulation in treating adults with amblyopia. The main questions it aims to answer are:\n\n1. What are the effects of non-invasive brain stimulation on neuronal plasticity in the visual cortex of adults with amblyopia, and does it produce lasting changes?\n2. Do cumulative sessions of non-invasive brain stimulation influence neural plasticity and higher-order visual functions in adults with amblyopia?\n\nThe investigators hypothesize that non-invasive brain stimulation will show a positive cumulative effect after five (5) consecutive days of stimulation on visual perception and function in adults with amblyopia.\n\nParticipants will be randomized into one of two treatment groups:\n\n1. High-frequency transcranial random noise stimulation (hf-tRNS).\n2. Sham stimulation.\n\nResearchers will compare baseline measurements of crowded visual acuity, contrast sensitivity, stereoacuity, phosphene thresholds, global motion perception, form pattern recognition and pattern-reversal visual evoked potentials (VEPs) to post-treatment measurements for each group.",[78],"Amblyopia",[78,80,81,82,83],"Non-invasive Brain Stimulation","Transcranial Random Noise Stimulation","Visual Perception","Visual Evoked Potentials","2024-12-09",{"date":86,"type":32},"2024-12-12",{"date":88,"type":32},"2024-05-01",{"date":90,"type":20},"2028-12-31",{"name":38,"class":39},{"id":93,"slug":94,"hasResults":11,"nctId":95,"briefTitle":96,"officialTitle":97,"acronym":98,"eligibilityCriteria":99,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":100,"enrollmentInfo":101,"targetDuration":4,"studyType":21,"phases":103,"briefSummary":104,"conditions":105,"keywords":107,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":111,"lastUpdatePostDateStruct":112,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":117,"locationsCount":40},"100506682","non-invasive-brain-stimulation-for-treating-symptomatic-convergence-insufficiency-100506682","NCT05877560","Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency","A Randomized Controlled Study Using Non-invasive Brain Stimulation to Facilitate the Effectiveness of Vergence\u002FAccommodative Therapy in Symptomatic Convergence Insufficiency","NIBSCI","Inclusion Criteria:\n\n* Best-corrected visual acuity of \\> 20\u002F25 in each eye at distance and near\n* Exophoria at near at least 4∆ greater than at far\n* Receded near point of convergence of \\> 6 cm break\n* Insufficient positive fusional vergence at near (\\\u003C 15∆ base-out blur or break)\n* CISS score of 16 and greater for children or 21 and greater for adults\n* Have had a dilated fundus examination within the last 12 months\n* Informed consent and willingness to participate in the study and be randomized\n\nExclusion Criteria:\n\n* Previously treated for convergence insufficiency with home- or office-based vergence\u002Faccommodative therapy\n* Amblyopia (\\> 2-line difference in best-corrected visual acuity between the two eyes)\n* Constant strabismus\n* History of strabismus surgery\n* Convergence insufficiency secondary to acquired brain injury or neurological disorder\n* Manifest or latent nystagmus\n* Systemic disease known to affect accommodation, vergence, and ocular motility including multiple sclerosis, Graves disease, myasthenia gravis, Parkinson's disease, cerebral palsy, and diabetes\n* Developmental disability, attention deficit hyperactivity disorder (ADHD), learning disability or cognitive dysfunction that would interfere with treatment\n* Taking medications that can affect normal neurological function including antipsychotics, antiepileptics, and opioids\n* Presence of metal or electronic implants in or on the body, including pacemakers","40 Years",{"count":102,"type":20},150,[23],"The goal of this randomized controlled trial is to test the effectiveness of non-invasive brain stimulation in treating adults with symptomatic convergence insufficiency compared to vergence\u002Faccommodative therapy. The main questions it aims to answer are:\n\n1. Can non-invasive brain stimulation shorten the treatment time of office-based vergence\u002Faccommodative therapy for convergence insufficiency?\n2. Is non-invasive brain stimulation alone just as effective as office-based vergence\u002Faccommodative therapy in treating convergence insufficiency?\n\nThe investigators hypothesize that non-invasive brain stimulation will shorten the treatment time from 12 weeks to 8 weeks of office-based vergence\u002Faccommodative therapy and that non-invasive brain stimulation alone would be equally effective as office-based vergence\u002Faccommodative therapy in improving symptomatic convergence insufficiency.\n\nParticipants will be randomized into one of three treatment groups:\n\n1. Non-invasive brain stimulation with office-based vergence\u002Faccommodative therapy.\n2. Sham stimulation with office-based vergence\u002Faccommodative therapy.\n3. Non-invasive brain stimulation only.\n\nResearchers will compare baseline measurements of near point of convergence (NPC) and positive fusional vergence (PFV) to post-treatment measurements for each group.",[106],"Convergence Insufficiency",[106,80,108,109,110],"Office-Based Vergence\u002FAccommodative Therapy","Frontal Eye Fields","Transcranial Direct Current Stimulation","2024-11-27",{"date":113,"type":32},"2024-12-02",{"date":115,"type":20},"2025-03-01",{"date":90,"type":20},{"name":38,"class":39},""]